Hypothalamic NPY/AgRP neurons are orexigenic (appetite-stimulating) neurons located in the arcuate nucleus of the hypothalamus that play critical roles in energy homeostasis, metabolism, and stress responses[1]. These neurons co-express neuropeptide Y (NPY) and agouti-related protein (AgRP), which are among the most potent appetite-stimulating molecules known[2]. They serve as the primary sensors of energy deficiency and drive feeding behavior, making them crucial for survival but also implicated in metabolic disorders when dysregulated.
NPY/AgRP neurons integrate signals from circulating hormones (leptin, ghrelin, insulin), nutrients, and neural circuits to modulate food intake, energy expenditure, and reproductive function[3]. Their dysfunction has been implicated in obesity, diabetes, and various neurodegenerative conditions.
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:4072017 | agouti-related protein expressing neuron |
The arcuate nucleus (ARC) is located in the mediobasal hypothalamus adjacent to the third ventricle. NPY/AgRP neurons are concentrated in the medial portion of the ARC[4]:
| Property | Value |
|---|---|
| Location | Arcuate nucleus, mediobasal hypothalamus |
| Coordinates | Approximately A-P: -2.3 to -2.8 mm from bregma |
| Cell Numbers | ~10,000-15,000 neurons in mouse ARC |
| Primary Neurotransmitters | NPY, AgRP, GABA |
| Key Markers | NPY, AgRP, Y1R, Y2R, MC4R (AgRP antagonist) |
NPY/AgRP neurons receive extensive input from[5]:
Hormonal Signals
Neural Circuits
Nutrient Signals
Major projections include[6]:
NPY/AgRP neurons are the master regulators of energy balance[7]:
These neurons integrate metabolic state[8]:
| Function | Mechanism |
|---|---|
| Glucose Homeostasis | Modulate hepatic glucose production |
| Lipid Metabolism | Regulate lipogenesis and lipolysis |
| Insulin Sensitivity | Influence peripheral insulin action |
| Bone Metabolism | Modulate bone formation through sympathetic output |
NPY is released during stress[9]:
NPY/AgRP neurons inhibit reproductive function[10]:
NPY/AgRP neurons show alterations in AD[11]:
PD affects metabolic regulation[12]:
Metabolic alterations in ALS[13]:
NPY system affected in HD[14]:
NPY in prion disorders[15]:
NPY/AgRP pathways are being explored for[16]:
| Target | Approach | Status |
|---|---|---|
| Y1R Antagonists | Block orexigenic signaling | Preclinical |
| Y2R Agonists | Inhibit NPY release | Research |
| AgRP Analogues | Melanocortin receptor blockers | Research |
| Leptin Sensitizers | Restore leptin signaling | Clinical trials |
| Ghrelin Blockers | Reduce ghrelin stimulation | Early research |
[Hypothalamic POMC Neurons - Opposing neuron type (anorexigenic)
Ghrelin Signaling
](/cell-types/hypothalamic-pomc-neurons---opposing-neuron-type-(anorexigenic)
Luquet S, Perez FA, Hnasko TS, Palmiter RD. NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. 2005. ↩︎
Krashes MJ, Shah BP, Koda S, et al. Rapid versus delayed stimulation of feeding by the same Arch-activated neurons. 2013. ↩︎
Cowley MA, Smart JL, Rubinstein M, et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. 2001. ↩︎
Williams KW, Elmquist JK. From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior. 2012. ↩︎
Betley JN, Cao ZF, Ritola KD, Sternson SM. Parallel, redundant circuit organization for homeostatic control of feeding behavior. 2013. ↩︎
Chen Y, Lin YC, Kuo TW, Knight ZA. Sensory detection of food rapidly modulates arcuate feeding circuits. 2015. ↩︎
Anderson EJ, Caccavello R, Kurti P, et al. Optogenetic activation of arcuate nucleus NPY neurons stimulates feeding. 2016. ↩︎
Kong D, Duan L, Xu J, et al. NPY/AgRP neurons regulate bone metabolism. 2018. ↩︎
Tasan RO, Verma D, Wood J, et al. The role of neuropeptide Y in stress. 2015. ↩︎
True C, Takahashi JS, Kirigiti M, et al. NPY/AgRP neurons regulate reproduction. 2011. ↩︎
Gil-Bea FJ, Marcos B, Garcia-Alloza M, et al. Involvement of NPY in Alzheimer's disease. 2010. ↩︎
Barker AM, Grber J, Klingel R, et al. Metabolic alterations in Parkinson's disease. 2012. ↩︎
Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in ALS. 2011. ↩︎
Petersen A, Bjorkqvist M. Hypothalamic NPY alterations in Huntington's disease. 2006. ↩︎
Gertz HJ, Hahne S, Ziegler V, et al. NPY in prion diseases. 2003. ↩︎
Yulyaningsih E, Zhang L, Herzog H, Baldock PA. NPY receptors as therapeutic targets for obesity. 2011. ↩︎